June 22, 2026 · Gynecologic oncology reports · DOI: 10.1016/j.gore.2026.102140

Vaginal dilator therapy for pelvic cancer patients: a review

Listen to this summary

This review examines the effectiveness of vaginal dilator therapy for pelvic cancer patients suffering from vulvovaginal atrophy, which is exacerbated by cancer treatments that induce estrogen deficiency. The authors aim to determine how this therapy can prevent complications such as vaginal stenosis and improve sexual function, while also addressing the challenges of patient adherence to the recommended usage. They suggest that enhanced education and support may improve adherence and therapeutic outcomes.

Navya Nair, Sara Brenner, Amanda Rivera, Barbara Norquist, B J Rimel

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play